Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of complement inhibitors for the preparation of a pharmaceutical for the prophylaxis and therapy of inflammatory intestinal and skin disorders as well as purpura

Use of complement inhibitors for the preparation of a pharmaceutical for the prophylaxis and therapy of inflammatory intestinal and skin disorders as well as purpura

US Patent 6248365 · Granted Jun 19, 2001

Estimated economic value: $7,848,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Process for production of fibrinogen and fibrinogen produced thereby2022
Modified von Willebrand factor having improved half-life2021
Process for production of fibrinogen and fibrinogen produced thereby2018
Factor XII inhibitors for the administration with medical procedures comprising 2018
Factor XII inhibitors for the treatment of silent brain ischemia and ischemia of2017
Use of C1-inhibitor for the treatment of secondary edema of the central nervous 2016
Factor XII inhibitors for the administration with medical procedures comprising 2016
von Willebrand factor or factor VIII and von Willebrand factor for the treatment2015
von Willebrand factor or factor VIII and von Willebrand factor for the treatment2013
Synergistic therapeutic use of prothrombin complex concentrates with FVIII conc2013
Dosage form for hormonal contraception2013
Synergistic therapeutic use of Prothrombin Complex Concentrates with FVIII conce2013